Metabolism, uptake, and transepithelial transport of the stereoisomers of Val-Val-Val in the human intestinal cell line, Caco-2

Pharmaceutical Research

Volumn 13, Issue 11, 1996, Pages 1663-1667

  Tamura, Kiyoshi ^a   Lee, Chao Pin ^b   Smith, Philip L ^b   Borchardt, Ronald T ^a  

^a UNIVERSITY OF KANSAS   (United States)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Caco 2; Cephalexin; Metabolism; Oligopeptide transporter; Structure transport; Tripeptides

Indexed keywords

CEFALEXIN; CEPHALOSPORIN DERIVATIVE; OLIGOPEPTIDE; TRIPEPTIDE;

ARTICLE; CELL MEMBRANE PERMEABILITY; CELL STRAIN CACO 2; DRUG DEGRADATION; DRUG TRANSPORT; HUMAN; HUMAN TISSUE; INTESTINE CELL; PRIORITY JOURNAL; STEREOISOMERISM; STEREOSPECIFICITY; TRANSPORT KINETICS;

BIOLOGICAL TRANSPORT; CACO-2 CELLS; CEPHALEXIN; CEPHALOSPORINS; DIPEPTIDES; EPITHELIUM; HUMANS; INTESTINAL ABSORPTION; OLIGOPEPTIDES; STEREOISOMERISM;

EID: 0030455379     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1016436606183     Document Type: Article

References (21)

1. C. H. Gochoco, F. M. Ryan, J. Miller, P. L. Smith, and I. J. Hidalgo. Int. J. Pharm. 104:187-202 (1994).
2. V. H. Lee and A. Yamamoto. Adv. Drug Del. Rev. 4:171-207 (1990).
3. D. I. Friedman and G. L. Amidon. Pharm. Res. 6:1043-1047 (1987).
4. M. Hu and G. L. Amidon. J. Pharm. Sci. 77:1007-1011 (1988).
5. H. W. Kleemann, H. Heitsch, R. Henning, W. Kramer, W. Kocher, W. Lerch, W. Rinz, W. U. Nickel, D. Ruppert, H. Urbach, R. Utz, A. Wagner, R. Weck, and F. Wiegand. J. Med. Chem. 35:559-567 (1992).
6. K. Tamura, P. K. Bhatnagar, J. S. Takata, C.-P. Lee, P. L. Smith, and R. T. Borchardt. Pharm. Res. 13:1222-1227 (1996).
7. I. J. Hidalgo, T. J. Raub, and R. T. Borchardt. Gastroenterology 96:736-749 (1989).
8. G. Wilson, I. F. Hassan, C. J. Dix, I. Williamson, R. Shah, M. Mackay, and P. Artursson. J. Control. Rel. 11:25-40 (1990).
9. D. Wessel and U. I. Flugge. Anal. Biochem. 138:141-143 (1984).
10. P. J. Chikhale and R. T. Borchardt. Drug Metab. Disp. 22:592-600 (1994).
11. S. Howell, A. J. Kenny, and A. J. Turner. Biochem. J. 284:595-601 (1992).
12. P. F. Augustijns and R. T. Borchardt. Drug Metab. Disp. 23:1372-1378 (1995).
13. A. R. Hilgers, R. A. Conradi, and P. S. Burton. Pharm. Res. 7:902-910 (1990).
14. D.-C. Kim, P. S. Burton, and R. T. Borchardt. Pharm. Res. 10:1710-1714 (1993).
15. W. Rubas, N. Jezyk, and G. M. Grass. Pharm. Res. 10:113-118 (1993).
16. W. Rubas, J. Villagran, M. Cromwell, A. McLeod, J. Wassenberg, and R. Mrsny. s.t.p. Pharma. Sci. 5:93-97 (1995).
17. B. H. Stewart, O. H. Chan, R. H. Lu, E. L. Reyner, H. L. Schmid, H. W. Hamilton, B. A. Steinbaugh, and M. D. Taylor. Pharm. Res. 12:693-699 (1995).
18. K. I. Inui, T. Okano, H. Maegawa, M. Kato, M. Takano, and R. Hori, J. Pharmacol. Exp. Ther. 247:235-241 (1988).
19. H. Saito and K.-I. Inui. Am. J. Physiol. 265:G289-G294 (1993).
20. S.-I. Matumoto, H. Saito, and K.-I. Inui. J. Pharmacol. Exp. Ther. 270:498-504 (1994).
21. D. T. Thwaites, C. D. A. Brown, B. H. Hirst, and N. L. Simmons. J. Biol. Chem. 268:7640-7642 (1993).